We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGSS
5276
DELISTED
Pegasus Digital Mobility Acquisition Corp.
PGSS
$3K ﹤0.01%
315
– –
ESACU
5277
DELISTED
ESGEN Acquisition Corporation Unit
ESACU
$3K ﹤0.01%
274
– –
GOL
5278
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$3K ﹤0.01%
1,207
-2,578
-68% -$6.95K
ID
5279
DELISTED
PARTS iD, Inc.
ID
$3K ﹤0.01%
12,964
+1,829
+16% +$988
KVSA
5280
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$3K ﹤0.01%
315
-869
-73% -$8.77K
TDSA
5281
DELISTED
Cabana Target Drawdown 5 ETF
TDSA
$3K ﹤0.01%
136
+48
+55% +$1.01K
ITAQ
5282
DELISTED
Industrial Tech Acquisitions II, Inc. Class A Common Stock
ITAQ
$3K ﹤0.01%
250
+25
+11% +$258
NFNT.U
5283
DELISTED
Infinite Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
NFNT.U
$3K ﹤0.01%
309
– –
RVLP
5284
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$3K ﹤0.01%
+2,645
New +$3.17K
BTWN
5285
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$3K ﹤0.01%
305
-793
-72% -$7.95K
OFED
5286
DELISTED
Oconee Federal Financial Corp.
OFED
$3K ﹤0.01%
+169
New +$3.6K
CRECU
5287
DELISTED
Crescera Capital Acquisition Corp Unit
CRECU
$3K ﹤0.01%
263
– –
EOCW.U
5288
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
$3K ﹤0.01%
340
– –
ONCR
5289
DELISTED
Oncorus, Inc.
ONCR
$3K ﹤0.01%
8,581
-21
-0.2% -$8
MTVC
5290
DELISTED
Motive Capital Corp II
MTVC
$3K ﹤0.01%
243
-12
-5% -$124
BLCM
5291
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3K ﹤0.01%
7,844
-3,676
-32% -$3.4K
BIOC
5292
DELISTED
Biocept, Inc.
BIOC
$3K ﹤0.01%
279
-1
-0.4% -$14
SI
5293
DELISTED
Silvergate Capital Corporation
SI
$3K ﹤0.01%
2,047
-55,998
-96% -$608K
IQMDU
5294
DELISTED
Intelligent Medicine Acquisition Corp. Unit
IQMDU
$3K ﹤0.01%
+300
New +$3.07K
IQMD
5295
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
$3K ﹤0.01%
+263
New +$2.7K
SRNE
5296
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3K ﹤0.01%
8,316
-5,176
-38% -$4.64K
FFBW
5297
DELISTED
FFBW, Inc. Common Stock
FFBW
$3K ﹤0.01%
252
-9
-3% -$108
BXRX
5298
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$3K ﹤0.01%
1,548
+1,247
+414% +$3.17K
SRAX
5299
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$3K ﹤0.01%
4,423
+644
+17% +$1.21K
SIVB
5300
DELISTED
SVB Financial Group
SIVB
$3K ﹤0.01%
3,050
+1,580
+107% +$444K
210 211
212
213 214

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.